The 2018 STS Intermacs Meeting is underway! During sessions today & tomorrow, over 100 attendees will learn about patient-reported outcomes, clinical trials, and new technologies related to FDA-approved mechanical circulatory support devices used to treat advanced heart failure.

La escala INTERMACS es una herramienta que nos ayuda a estratificar el pronóstico de pacientes con IC avanzada.

Perfiles #INTERMACS(4-7) #InsuficienciaCardiaca avanzada •Mejor predictor q CF NYHA •50% desacuerdo al clasificarlos por otros niveles d atención🔜derivar ⏩Especialista: Mejor caracterización •CF III; estable⁉️🔜enfermo y va mal •Seguimos sin score? https://t.co/xk9VyhEcEd

Superstar resident ⁦@YaleMedicine⁩ presenting our findings from #intermacs that were published simultaneously in ⁦@JAMACardio⁩ - we noted clinical benefit of NHB post LVAD #AHA2019 ⁦@YaleCardiology⁩

Hi again! Ecpella hypothetical case study. A 🧵 28yo 👨‍🦰with end stage DCM on the urgent list for heart transplantation ( milrinone dependent, INTERMACS 3) . VT storm today --> deterioration to INTERMACS 1 (crash and burn) pVA ECMO inserted. Flow 4lpm CXR post ECMO insertion

Please join is tomorrow for the first in a series of free, monthly webinars focused on the care of patients with advanced HF. Episode #1: 🔘Contemporary Outcomes of LVADs, INTERMACS update, Dr. Kevin Koomalsingh 🔘Contemporary Outcomes of Heart Transplant, Dr. Jill Gelow

Día de Trasplante Cardiaco @Cardiologia_Mx Mujer 54 años, Insuficiencia Cardíaca sec. a cardiotoxicidad por antraciclicos (quimioterapia). INTERMACS 3 📷 izquierda Corazón enfermo con IC Avanzada 📷 derecha Corazón donado listo para latir en su nuevo hogar (belleza de órgano)

Trasplante🫀en emergencia con #ECMO-VA/ARM INTERMACS 2 2️⃣do en nuestro país con este soporte🙌🏻los dos en nuestro programa Ya sin ARM (48hs) & en rehabilitation (PGD superada) Desafío previo del 16🫣PGD severa con #ECMO-VA (en 🏠) 1️⃣7️⃣trasplantes en 18 meses La responsabilidad

📌Sacubitril/Valsartan in Advanced Heart Failure with Reduced Ejection Fraction: Rationale/Design of the LIFE Trial Look forward 🙌🏻‼️ Limited experience with S/V in patients with advanced #HF @JACCJournals https://t.co/6XNSrMF1Pw #INTERMACS

AQO 2019 is underway in New Orleans! Day one features sessions on the General Thoracic Surgery Database and the STS Intermacs Database. This is the first AQO Meeting to feature a full day of Intermacs presentations #AQO2019

I NEED HELP: identifying patients who need advanced therapies for HF. 🔺Integrating ACC, NYHA and INTERMACS classifications. 🔺Early referral is always better for the patient. 🔺Use of an acronym-I NEED HELP-can prove to be a useful tool for cardiologists. #MacHF @hvanspall

I was asked recently if IABPs still have any role. Absolutely - look at this ❤️ , intermacs 2 ->supported very well with axillary IABP (seen on CXR) bridge to transplant.

Tercer trasplante cardíaco del 2021 🤩 Con ECMO VA como puente al trasplante en paciente en INTERMACS 1 ♥️ @leonardo_seoane @MirtaDiez4

The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships - #QualityReport from Kormos et al: https://t.co/O9nXrmVg2W #TSSMN #AnnalsImages

Utilidad escala INTERMACS en seleccion terapias avanzadas IC. @eduardo_barge

Fantastic analysis in the current @JAMACardio: Amongst >12.000 patients with LVAD from the #INTERMACS registry, treatment using neurohormonal blockade (ACE-I, ARB, MRA and betablockers) associated with improved survival and quality of life! #Cardiotwitter #CardioEd #LVAD

Lo que siempre se ha manifestado INTERMACS abarca CFII, lo dijo hace dos años la Prof. Crespo al presentar el consenso. Todos estos 👥 deben ser evaluados por un especialista para poder determinar la necesidad de terapias avanzadas; manejo conjunto con su cardiólogo de cabecera.

Congratulations to Sylvia M. Laudun, RN, who received the Sherri Ann Wissman Memorial Excellence Award in recognition of outstanding performance in mechanical circulatory support at the 2018 STS Intermacs Meeting, held this past weekend. View more photos: https://t.co/G5TXQ0tqdY

Alternative to current management of biventricular failure: long term support of INTERMACS 1-2 pts based on innovative approach using an HeartWare VAD as left ventricular LV-HVAD + right atrial RA-HVAD: largest successful series to date #LVAD #RVAD #MCS https://t.co/hidpraVpS9